PCI The Journeys Within
Media Pack
News

Current Edition

JCS - Volume 18 Issue 3 - Autumn 2026
Frankfurt 2027 – 12/10/26
ramusmedical
Volume 13 Issue 6

Unlocking the Business Benefits of Text Mining in Regulatory Operations

As IDMP implementation advances in Europe, data is becoming a key asset for the life sciences industry. Currently, pharma companies are focusing on the heavy burden o...
9 December 2021 Volume 13 Issue 6 data collection | data maintenance
Continue Reading →
Regional News

Amid a push to resolve opioid and talc claims, Johnson & Johnson settles Risperdal litigation for $800M

Over the last few months, Johnson & Johnson has made sweeping moves to resolve a mountain of litigation involving the safety and marketing of its opioid and talc ...
2 November 2021 Regional News J&J | Johnson & Johnson
Continue Reading →
Regional News

AstraZeneca resumes asset sale in $270M COPD deal with familiar buyer Covis

Over the years, AstraZeneca has consistently adjusted its portfolio, targeting aging products. The company has now found a new home for two respiratory meds with an o...
2 November 2021 Regional News AstraZeneca | clinical trial
Continue Reading →
Regional News

Bristol Myers Squibb previews new ‘transformation’ corporate brand campaign at annual global patients’ event

Bristol Myers Squibb’s new corporate campaign celebrates transformation—of science, the pharma industry and patients’ lives. It’s the pharma’s first corporate campaig...
29 September 2021 Regional News Bristol Myers Squibb | patient
Continue Reading →
Regional News

Ogilvy Health’s new PR practice chief talks pharma image and social trends

There’s a shifting focus in pharma public relations from image to impact, says Ogilvy Health’s new PR practice president. Shannon Walsh, recently tapped to lead publ...
18 August 2021 Regional News Bristol Myers Squibb | Johnson & Johnson
Continue Reading →
Europe

Cannabics Pharma clinches clinical trial on Cannabics SR 5mg for CACS

The company is awaiting for the results and expect them to further clarify an important part of their mission in integrating cannabinoid-based therapies into the worl...
11 July 2018 Europe 5mg | CACS
Continue Reading →
Europe

Xynomic Pharma Plans 4 Clinical Trials of Abexinostat for Lymphoma

 Xynomic Pharma announced it has completed a new Series B financing round and now will initiate eight clinical trials, four of which are for different types of lympho...
13 June 2018 Europe Abexinostat | clinical
Continue Reading →
Europe

Chris Blanton Joins PCI Pharma Services as Vice President of Global Operations Strategy and Program Management

 Blanton to support ongoing PCI Pharma Services growth and expansion initiatives Leading global pharmaceutical outsourcing provider PCI Pharma Services is pleased to ...
13 June 2018 Europe Blanton | Chris
Continue Reading →
Europe

Redx Pharma up as it confirms cancer drug clinical trial will re-start early next year

Redx is developing a new generation of cancer drug called a porcupine inhibitor After discussions with the re...
31 May 2018 Europe cancer | clinical
Continue Reading →
Europe

VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) to develop and commercialise CR845/difelikefalin injection worldwide except in the US, Japan and South Korea for...
23 May 2018 Europe | news care | Fresenius
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte